Overview
- 5 inspections across 5 sites are on record.
- 1 Form 483 observation is attributed to this investigator.
- Most recent recorded activity is 2014-09-29.
At a glance
Inspections
5
Sites
5
Observations
1
Career since
Aug 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Nova Laboratories Ltd. | 29 Sep 2014 | Biologics | On file |
| NOVA LABORATORIES LIMITED | 29 Sep 2014 | Biologics | On file |
| ALBA Bioscience Limited dba Quotient Biodiagnostics Inc. | 25 Feb 2011 | On file | |
| AstraZeneca Pharmaceuticals LP | 9 Oct 2009 | On file | |
| Immucor, Inc. | 15 Aug 2008 | On file |
Sites inspected
Nova Laboratories Ltd.Wigston, United Kingdom1 insp.
NOVA LABORATORIES LIMITEDWigston, United Kingdom1 insp.
ALBA Bioscience Limited dba Quotient Biodiagnostics Inc.Edinburgh, United Kingdom1 insp.
AstraZeneca Pharmaceuticals LPPhiladelphia, United States1 insp.
Immucor, Inc.Peachtree Corners, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Christine Harman2 shared
Edward Patten1 shared
Ann M Montemurro1 shared
Nawab A Siddiqui1 shared
Marion Michaelis1 shared
Full investigator report
Get the verbatim findings behind Susan S Yu's 1 observation
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site